Return to top
rfxcel with MVC for the safety of the Kingdom of Bahrain’s pharmaceutical supply chain process
rfxcel with MVC for the safety of the Kingdom of Bahrain’s pharmaceutical supply chain process

Share on

Date

07 June 2021

rfxcel with MVC for the safety of the Kingdom of Bahrain’s pharmaceutical supply chain process

The first GS1-compliant system to track its entire pharmaceutical supply chain on a blockchain platform will be provided

rfXcel has successfully implemented an end-to-end traceability hub to monitor and secure the Kingdom of Bahrain’s global pharmaceutical supply chain process.


GREAT NEWS! 

Discover the Antares Vision Radio, click here to listen to this article:

English Version - Italian Version


Bahrain’s National Health Regulatory Authority (NHRA) and Supreme Council of Health selected Medical Value Chain, “MVC” and its partner rfXcel to provide the first GS1-compliant system to track its entire pharmaceutical supply chain on a blockchain platform.

rfxcel with MVC have implemented an end-to-end traceability hub for Kingdom of Bahrain’s

HOW DOES THE END-TO-END TRACEABILITY HUB WORK?

The end-to-end traceability hub delivers complete visibility into every node of Kingdom’s supply chain, from the manufacturer of origin, importers, wholesalers, and distributors to pharmacies, clinics, and hospitals - all the way to individual patients.


The NHRA traceability HUB of Bahrain has the following objectives:

  • End-to-end traceability for all medicine imports to Bahrain;
  • Bahrain pharma supply chain to meet the global track & trace requirements and GS1 Standards;
  • Complete visibility and repository of medicine inventory & supply-chain info from manufacturers to agents/importers to wholesalers/distributors to pharmacies/hospitals and to patients/consumers;
  • Increase patient safety;
  • Detect and stop counterfeit medicines;
  • Analytics of medicine imports and consumptions in Bahrain;
  • Manage product recalls and shortages efficiently and timely.

 

“I am honoured that the Kingdom of Bahrain chose Antares Vision Group in partnership with MVC to secure and optimize its pharma supply chain. Soon, we expect to announce national traceability hubs in other countries to track pharmaceutical, agricultural and consumer products”, Emidio Zorzella, Antares Vision Group CEO, said.

 

“This hub creates a single source of truth for all medications, which means improved patient safety, better flow of information, and more accurate inventory management. It is also a powerful tool to prevent counterfeit and substandard drugs from reaching the market”, Glenn Abood, rfXcel CEO, said.

Comments

No comments have been posted yet. Please feel free to comment first!

Leave or Reply a comment for this article

preloader